Lattice corneal dystrophy (LCD) is a bilateral, local amyloidosis, characterized by variation in the corneal manifestations, clinical course, and genetics.1 LCD has been attributed to TGFBI (transforming growth factor, beta-induced) gene on human chromosome 5q31 (OMIM No. 601692). LCD type II is associated with secondary open-angle glaucoma in the context of familial amyloidosis, Finnish (FAF).2 We report a case with the corneal findings of LCD type II but without any systemic involvement, in a patient with juvenile glaucoma.

Case report

A 26-year-old woman was referred to the glaucoma clinic because of elevated intraocular pressure (IOP) found in a routine eye examination. The patient was otherwise healthy with no significant family history, no visual complaints, or any history of recurrent erosions.

Her best-corrected visual acuity was 20/20 in both eyes. Corneal sensitivity was normal. Slit-lamp examination revealed refractile, radial filamentary lines in the anterior corneal stroma creating a lattice-work pattern, with sparing of the central cornea (Figure 1). No opacification or corneal haze was noted.

Figure 1
figure 1

The patient's cornea is shown with refractile and discrete filamentary lines in the anterior stroma creating a lattice-work pattern. A white round dot in the anterior corneal stroma corresponding to an epithelial irregularity is remarkable. Note the absence of opacification, as well as the sparing of the central cornea.

Gonioscopy showed high iris insertion and prominent iris processes in both eyes (Figure 2). IOP was 34 mmHg in the right eye and 29 mmHg in the left eye. Fundus examination revealed an arcuate nerve fibre loss between the first-order inferior temporal vessels of the left eye. Visual fields were normal. No change in the findings of the cornea, fundus, and visual fields was noted within the 5 years of follow-up. IOP remained controlled under antiglaucoma treatment.

Figure 2
figure 2

High iris insertion and prominent iris processes seen on gonioscopy.

Familial and systemic amyloidosis were ruled out by extensive physical examination and laboratory work-up. The patient did not present any skin lesions, macroglossia, arrhythmias or megalocardy, hepatosplenomegaly, arthritis, and cranial or peripheral neuropathy. There was no evidence of pulmonary, haematopoetic, or renal involvement. ESR, CRP, and immunoglobulins levels were within normal limits. Echocardiography was normal. Skin biopsy was negative for amyloid deposition. Blood samples were taken for DNA analysis after voluntary informed signed consent was obtained using the Thessaloniki IRB consent. Screening for the two mutation hotspots within the TGFB1 gene using sequencing did not reveal the common mutations present in the majority of patients with LCD (R124L, R124C, R124H, R555W, R555Q).

Comment

Despite the typical for FAF corneal picture, vision preservation and age of onset in that patient, the absence of systemic involvement within the 5 years of follow-up is indicative of a localized form of LCD. Furthermore, our patient suffered from juvenile and not secondary glaucoma. These clinical findings are not representative of any of the common isolated forms reported in the past.1, 3 This is suggestive of a more pleomorphic appearance of the isolated LCDs, and it is in agreement with conclusions made by Stewart et al4 on the validity of LCDs' current classification.